Multimodal Music Therapy for Children With Anxiety Disorders
A Randomized Controlled Trial of Multimodal Music Therapy for Children With Anxiety Disorders
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
Multimodal music therapy (MT) for children ages 8 to 12 years with anxiety disorders is compared to community treatment as usual (TAU). 36 children were randomized either to MT or to TAU. Primary outcome is presence of an anxiety disorder at the end of treatment. Secondary outcomes are self- and parent-/teacher reported anxiety, co-morbid psychological symptoms, and quality of life. Stability of outcome is assessed six months after the end of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 anxiety
Started May 2006
Longer than P75 for phase_3 anxiety
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 3, 2010
CompletedFirst Posted
Study publicly available on registry
February 4, 2010
CompletedFebruary 4, 2010
May 1, 2006
2.6 years
February 3, 2010
February 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of an anxiety disorder (DSM IV)
Study Arms (2)
Multimodal music therapy
EXPERIMENTALMultimodal music therapy comprises 16 sessions single music therapy, group music therapy (max. 6 children/group), parent-child sessions, and parent counseling. The manualized treatment integrates music therapy, behavioral interventions, and family-oriented interventions.
community treatment as usual
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- age 8-12 years
- diagnosis of an anxiety disorder
- IQ\>80
- informed consent and assent
You may not qualify if:
- anxiety disorder is not primary focus of treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lutz Goldbeck, Ph.D.
University Ulm
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 3, 2010
First Posted
February 4, 2010
Study Start
May 1, 2006
Primary Completion
December 1, 2008
Study Completion
September 1, 2009
Last Updated
February 4, 2010
Record last verified: 2006-05